Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period ending March 31, 2018. The report details a capital increase approved by the Board of Directors on March 26, 2018, resulting from the exercise of stock options under the Company's 2013 Stock Option Plan.
Key Financial Metrics
The filing focuses on capital structure changes rather than operational performance. Key figures include:
- Capital Increase Amount: BRL 69,388,405.48
- New Capital Stock: BRL 57,710,201,914.77
- Shares Issued: 3,337,923 new common shares (no par value)
- Issuance Price: BRL 20.79 per share
- Potential Dilution: 0.02124%
Note: The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the increase in authorized capital stock and the issuance of new shares to option holders. The filing provides historical market price data for the last three years, quarters, and months, showing an average share price of BRL 22.26 over the last 90 days prior to issuance.
Outlook, Risks, and Management Commentary
Management commentary is limited to the procedural approval of the stock option exercise. No specific guidance, outlook, risks, contingencies, or unusual items regarding future operations are disclosed in this specific filing.
Investor Verification Checklist
- Verify the impact of the 0.02124% dilution on existing shareholder equity.
- Confirm the total number of outstanding shares post-issuance against the new capital stock figure.
- Review the 2013 Stock Option Plan terms to understand the vesting and exercise conditions for future issuances.
- Check subsequent filings for the actual cash proceeds received from the BRL 69.4 million capital increase.